Cardiovascular Events: Clinical Trials

6 trials for Cardiovascular Events, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 6 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 2, Unknown 2, Active not recruiting 1, Recruiting 1

Follow Cardiovascular Events: new trials by email Literature Review of Cardiovascular Events trials Research Report on Cardiovascular Events

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
PCSK9 inhibitors and background lipid-modifying therapy, Standard lipid-modifying therapy - Coronary Artery Disease, CT Angiography
Not applicableRecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine35962025-04-222026-02-06
Weight Management of Dialysis Patients
Family weight self-measurement and remote follow-up management based on wechat., Routine care - Hemodialysis, Life Quality
Not applicableUnknownqinxiu zhang1002024-04-012024-03-27
Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve Long-term Clinical Outcomes in MASLD
Hepatologic-provided recommendations, Nutritional support, Psychological support - MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD
Not applicableCompletedUniversity of Campania Luigi Vanvitelli2862023-07-012026-02-12
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
Placebo plus high-intensity statin, PCSK 9 Inhibitor plus high-intensity statin - Acute Coronary Syndrome, Hyperlipidemias
Not applicableActive not recruitingNanjing First Hospital, Nanjing Medical University12122023-03-302026-07-21
Post-stroke Depression Treatment Effect on Stroke Recurrence
Citalopram - Stroke Recurrence, Cardiovascular Events
Not applicableCompletedEge University12302017-02-112021-03-01
Social Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity -Interval Rehabilitation.
interval-rehabilitation - Cardiovascular Events
Not applicableUnknownClinic Roderbirken4802011-10-012012-05-02

Narrower conditions

Acute Coronary Syndrome (1)  ·  Coronary Artery Disease (1)  ·  Depression (1)  ·  Hyperlipidemias (1)  ·  Hypertension (1)  ·  Myocardial Infarction (1)  ·  Stroke (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Vascular Diseases (4)  ·  Heart Diseases (3)  ·  Myocardial Ischemia (3)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Coronary Disease (1)  ·  Dyslipidemias (1)  ·  Infarction (1)  ·  Ischemia (1)

Interventions

Citalopram (1)  ·  Cognitive Behavioral Therapy (1)  ·  Comorbidity (1)  ·  Nutritional Support (1)  ·  PCSK9 Inhibitors (1)

Sponsors

Clinic Roderbirken (1)  ·  Ege University (1)  ·  Nanjing First Hospital, Nanjing Medical University (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  University of Campania Luigi Vanvitelli (1)  ·  qinxiu zhang (1)

Countries

China (2)  ·  Germany (1)  ·  Italy (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)

Top investigators

Bon-Kwon Koo (1)  ·  Shao-Liang Chen, MD, PhD (1)  ·  Wolfgang Mayer-Berger, MD (1)  ·  Xinyang Hu (1)

Results publications

PMID 39910544, PMID 42805146